Armando Cordova is a Professor at Mid Sweden University's Department of Engineering, Mathematics and Science Education. His research focuses on sustainable materials, catalysis, and bioeconomy applications. Research Highlights: Development of heterogeneous catalytic systems for asymmetric synthesis Surface engineering of nanocellulose materials Integration of biocatalysis with metal catalysis in reactive extrusion Design of eco-friendly chemical transformations Research Projects: HIPS - Sustainable Innovations and Products in Forest Bioeconomy NeoPulp SusChemCell - Sustainable Cellulose-Based Materials Key Publications Trends: Recent works emphasize copper/palladium catalysis, organocatalytic surface modifications of nanocellulose, and asymmetric cascade transformations for pharmaceutical and sustainable materials applications.
Dr. Ayan Mukherjee (Assistant Professor Grade I) is affiliated with the School of Chemistry at IISER Thiruvananthapuram . He holds a Ph.D. in Organic & Medicinal Chemistry from CSIR-Indian Institute of Chemical Biology (2013-2019) and completed postdoctoral training at Baylor College of Medicine (2022-2024) and University of Manitoba (2021-2022). His academic journey includes an M.Sc. from IIT Madras (2011-2013) and a B.Sc. (Hons) in Chemistry from University of Calcutta (2008-2011). Ph.D.: CSIR-Indian Institute of Chemical Biology (2013-2019) M.Sc.: Indian Institute of Technology Madras (2011-2013) B.Sc. (Hons): University of Calcutta (2008-2011) Dr. Mukherjee's research focuses on organic synthesis and medicinal chemistry , particularly addressing antimicrobial resistance through innovative therapeutic strategies. His work combines computational drug discovery with experimental synthesis to develop novel antibiotics and adjuvants that enhance existing therapies against multidrug-resistant pathogens like ESKAPE species. Recent publications highlight advancements in PROTAC development , TLR7/9 antagonism , and chemical transformation techniques . Research trends from his articles include modular assembly for targeted protein degradation, TLR modulation for anti-inflammatory applications, and innovative approaches to antibiotic adjuvants. These studies demonstrate a consistent emphasis on translational chemistry bridging mechanistic insights with clinical relevance. Dr. Mukherjee actively recruits dedicated students for Ph.D. and M.Sc. project positions. Eligible candidates must hold an M.Sc. in Chemistry with interest in organic chemistry, or possess national fellowships like CSIR/UGC, INSPIRE, or equivalent.
Mark Taylor is a Professor in the Department of Chemistry at the University of Toronto, where he conducts research at the intersection of organic synthesis and supramolecular chemistry. His work focuses on noncovalent and reversible covalent interactions, with applications in designing chemical sensors and catalysts. Expertise: Catalyst development, mechanistic elucidation, receptor design, host-guest interactions Key research areas: Stereo- and regioselective catalysis, carbohydrate transformations, molecular recognition, sensory molecules, computational mechanistic studies His recent publications highlight innovations in organoboron/transition metal cocatalysis for carbohydrate functionalization, site-selective glycosylation methods, and halogen bonding applications in materials science. The majority of his work explores how organoboron compounds enable precise control over reaction regioselectivity and stereoselectivity, particularly in sugar chemistry. While no formal awards are listed, his administrative role as Associate Chair, Graduate Studies, underscores his institutional leadership.
Jesper Wengel serves as the Dean of the Faculty of Engineering and Science at Aalborg University (AAU), Denmark, where he leads academic and research initiatives. As a prominent researcher, his work has significantly advanced Oligonucleotide Biochemistry and Locked Nucleic Acid applications in therapeutic contexts. Role: Dean, Faculty of Engineering and Science, AAU (since December 1, 2024) Previous Affiliation: Pro-Dean for Innovation and Society at the University of Copenhagen His research focuses on Biochemistry , Genetics , and Molecular Biology , with emphasis on: DNA/RNA chemistry and modifications Therapeutic oligonucleotide design Biomolecular assembly and drug delivery systems Anti-gene clamps targeting neurodegenerative diseases Peptide-oligonucleotide conjugates Thiol conjugation techniques Recent publications highlight his expertise in Bioconjugate Chemistry and Nucleic Acid Therapeutics , particularly in: Modular albumin-Holliday junction systems for prolonged circulation Anti-gene oligonucleotide clamps for Huntington's disease Improved thiol conjugation for biomolecular stability He has also contributed to patent development in oligonucleotide-based therapeutics, though specific scientific awards are not detailed in the provided text.
Julian Stingele is a Professor (W2) at the Gene Center and Department of Biochemistry , Ludwig-Maximilians-Universität München, Germany. His research focuses on DNA repair mechanisms, particularly the resolution of DNA-protein crosslinks via proteases and ubiquitin signaling. PhD in Biology from Ludwig-Maximilians-Universität München (2015) Diploma in Biology from University of Konstanz (2010) His work bridges molecular and structural biology to uncover how cells maintain genome stability under DNA damage. Key areas include: DNA-protein crosslink repair Ubiquitin and SUMOylation in DNA damage response Protease functions in genome maintenance Transcription-coupled repair pathways Chemical carcinogenesis mechanisms RNA damage responses Julian's recent articles highlight advancements in DNA repair proteases (e.g., SPRTN, FANCJ), transcription-coupled repair pathways, and chemical methods for quantifying DNA lesions. His publications span high-impact journals like Cell , Nature Cell Biology , and Molecular Cell , emphasizing interdisciplinary approaches. Scientific Awards: 2023: ERC Consolidator Grant 'Deconstruct' 2021: Vallee Scholar Award 2020: EMBO Young Investigator 2019: Bayer Early Excellence in Science Award 2018: ERC Starting Grant 'DNAProteinCrosslinks' 2018: Alfried Krupp Prize for Young University Lecturers 2015: EMBO Long-Term Fellowship 2010: Max Planck Institute for Biochemistry Junior Research Award
Dr. Joanna Mcgouran is an Associate Professor in the Department of Chemistry at Trinity College Dublin, where she leads research in translational organic chemistry and chemical biology. She holds a 1st class MChem and D.Phil. from the University of Oxford and completed postdoctoral training in both the Department of Medicine and the Chemistry Department at Oxford, working with Professors Benedikt Kessler and Tom Brown, respectively. In 2016, she joined Trinity College Dublin as the Schuler Assistant Professor in Translational Organic Chemistry, advancing to Associate Professor. 1st class MChem, University of Oxford D.Phil., University of Oxford (Supervisor: Prof. Ben Davis) Postdoctoral Researcher, Department of Medicine, University of Oxford (Prof. Benedikt Kessler) Postdoctoral Researcher, Chemistry Department, University of Oxford (Prof. Tom Brown) Her research focuses on the development of activity-based probes and inhibitors targeting enzymes involved in DNA repair and ubiquitin signaling pathways. She investigates the mechanisms of nucleases like SNM1A and deubiquitinating enzymes using synthetic chemistry, biochemical assays, and proteomics. Her work aims to understand enzyme function in DNA damage response and develop novel therapeutic strategies for diseases including cancer. Her recent publications reveal a strong trend in designing chemical tools for probing enzyme activity, particularly through modified nucleosides, covalent labeling, and photocatalytic methods. She frequently publishes in high-impact journals such as Nature , ACS Chemical Biology , and Organic and Biomolecular Chemistry , emphasizing interdisciplinary approaches that bridge organic synthesis and biological application. MA, University of Oxford, 2009 Scholarship, University of Oxford, 2002–2005 Dr. Mcgouran has secured significant research funding from Science Foundation Ireland, the Irish Research Council, the Wellcome Trust, and Trinity College Dublin. Her funded projects support the development of probes for DNA processing enzymes, cyclic peptide inhibitors of nucleotide excision repair, and tools for studying p53 deubiquitination. While student names are not listed in the provided text, her active research group and grant leadership imply she mentors PhD and Master’s students. She leads multiple projects on disulfide modification, oligonucleotide probes, and activity-based profiling, often collaborating across disciplines. Her laboratory is involved in creating innovative chemical tools that enable precise interrogation of enzyme activity in live cells and disease models.
Sebastian Georg Zieglmeier is a Research Fellow at the University of Oslo's Faculty of Mathematics and Natural Sciences, affiliated with the Section for Autonomous Systems and Sensor Technologies. His research focuses on advanced control systems, energy systems, and machine learning applications such as reinforcement learning and deep learning. He explores modeling techniques for autonomous power systems and data-driven control strategies. His recent publications emphasize RNA engineering, therapeutic applications, and immunogenicity reduction in vaccines. Key areas include RNA purification, lipid-based formulations, and cancer-targeted agents. Zieglmeier's work bridges biotechnology and engineering, with contributions to molecular diagnostics and vaccine development. While no specific grants or awards are noted, his research aligns with cutting-edge technologies in mRNA therapeutics and autonomous systems. He is based at the University of Oslo's Institute of Transport Economics (ITS) and contributes to interdisciplinary projects at the Faculty of Mathematics and Natural Sciences.
Sebastian Demkowicz is an Associate Professor at Gdańsk University of Technology's Faculty of Chemistry, Department of Organic Chemistry, and currently serves as Vice-Dean for Student Affairs. His academic progression includes roles as assistant (2009–2010), assistant professor (2010–2018), and associate professor since 2018. He earned his PhD in Chemical Sciences (2009) and habilitation (2018) from Gdańsk Tech. Research focuses on drug design targeting breast cancer via steroid sulfatase (STS) inhibitors, organophosphorus chemistry, and mechanochemical synthesis. Key contributions include novel enzyme inhibitors (e.g., STS inhibitors based on triazole, coumarin, and flavone scaffolds) and studies on electron attachment mechanisms in nucleic acids. Publications (45+) span Journal of Medicinal Chemistry , European Journal of Medicinal Chemistry , and Scientific Reports . Awards include Rector Awards for scientific excellence (2009, 2016, 2018). He leads projects on drug discovery and acts on university committees (e.g., Faculty Recruitment Committee, Disciplinary Committee). Labs/teams: Active in organic synthesis and medicinal chemistry labs at Gdańsk Tech, collaborating on STS inhibitor development and radiation chemistry studies.
Dr. Marcelo Andrade Lima is a Lecturer in Biomedical Sciences at the School of Life Sciences, Keele University , where he serves as PGR Co-ordinator. He holds a PhD (2012) and post-doctoral experience (2014) in Molecular Biology from the Federal University of São Paulo, with prior degrees in Biology (2008) and Molecular Biology (2010) from the Federal University of Rio Grande do Norte. His research focuses on the structural and functional relationships of biological macromolecules , particularly glycosaminoglycans and heparin , with groundbreaking work on their roles in anticoagulant drug quality control, SARS-CoV-2 interaction mechanisms, and Alzheimer's disease pathogenesis . He also explores super-resolution microscopy and CARS (Coherent Anti-Stokes Raman Scattering) for cellular structure analysis. The most recent articles highlight his expertise in heparin's pharmacological applications (e.g., SARS-CoV-2 inhibition, anti-inflammatory strategies), biocatalytic systems for nucleotide sugar production, and marine-derived glycosaminoglycans with unique antithrombotic properties. His work bridges structural biology, biomedical chemistry, and translational research , often challenging established models of glycosaminoglycan biosynthesis. Dr. Lima's collaborations span institutions in the UK, Brazil, and beyond, with contributions to peer-reviewed journals in biochemistry, pharmacology, and virology . His lab employs advanced techniques like NMR spectroscopy, SPR analysis, and molecular dynamics simulations to dissect carbohydrate-protein interactions.
Masad J. Damha is a Distinguished James McGill Professor in the Department of Chemistry at McGill University. He holds a B.Sc. (1983) and Ph.D. (1988) from McGill University and completed postdoctoral training at the California Institute of Technology. His research bridges chemical biology and synthesis/catalysis, focusing on the chemical synthesis, biochemical properties, and molecular behavior of nucleosides, nucleic acids, and their analogues, with applications in biotechnology including siRNA, antisense oligonucleotides, and aptamers. Research Interests: Professor Damha's work explores inter- and intracellular communication between nucleic acids and proteins, particularly investigating how chemically modified nucleic acids (e.g., ANA, 2’F-ANA) can enhance therapeutic efficacy. His research aims to develop novel strategies for genetic regulation and diagnostic tools through engineered nucleic acid systems. Honors and Awards: R.U. Lemieux Award (CIC, 2020) Queen Elizabeth II Diamond Jubilee Medal (2012) Bernard Belleau Award (CSC/CIC, 2007) Merck-Frosst Award for Therapeutic Research (1999) Fellow of the Chemical Institute of Canada (FCIC, 1999) John Charles Polanyi Chemistry Prize (1989) Leo Yaffe Award for Excellence in Teaching (2011-12) David Thomson Award in Graduate & Teaching (2010) Teaching and Leadership: Professor Damha teaches Introductory Organic Chemistry (CHEM 302) and Advanced Nucleic Acid Chemistry (CHEM 542). He has held leadership roles as President of the International Society of Nucleosides, Nucleotides & Nucleic Acids (2019-20) and the Oligonucleotide Therapeutics Society (2013-14).
John Chaput is a Professor in the Department of Chemistry at the University of California, Irvine. His research focuses on chemical biology, synthetic nucleic acids, and biomolecular engineering. He leads efforts to design novel genetic polymers like XNA (xeno-nucleic acid) and TNA (threose nucleic acid), exploring their applications in diagnostics, therapeutics, and synthetic biology. Chaput’s work emphasizes functional nucleic acid engineering, including the development of XNAzymes for gene silencing and diagnostic systems. His lab employs directed evolution, microfluidics, and structural biology techniques to enhance polymerase efficiency and nucleic acid stability. Key areas of innovation include the REVEALR diagnostic platform for rapid pathogen detection, advances in TNA polymerase evolution, and the synthesis of stable nucleic acid analogs resistant to biological degradation. Chaput’s research bridges organic chemistry, enzymology, and molecular biology, with implications for drug delivery, genetic engineering, and understanding fundamental replication mechanisms. His contributions span over 150 peer-reviewed publications, with recent work highlighting nucleic acid therapeutics, cross-species genetic systems, and the structural basis of DNA replication. Chaput collaborates with industry partners to translate lab discoveries into clinical diagnostics and therapies.
Tynchtyk Amatov is an Assistant Professor of Chemistry at New York University Abu Dhabi, affiliated with the Division of Science. His research focuses on catalysis, natural product synthesis, medicinal chemistry, and nucleic acids chemistry, with a particular emphasis on sustainable methodologies and applications in chemical biology. Prior to NYUAD, he conducted postdoctoral research at the Max-Planck-Institut für Kohlenforschung with Benjamin List and at LMU Munich under Thomas Carell, exploring origin-of-life chemistry and radical mechanisms. Amatov holds a BSc and MSc from Lomonosov Moscow State University and a PhD from Charles University in Prague/IOCB Prague under Ullrich Jahn. His work bridges synthetic organic chemistry and prebiotic chemistry, addressing questions about early Earth molecular systems through radical-based synthetic strategies. His current research emphasizes developing new catalytic systems for natural product synthesis and exploring prebiotic pathways for nucleic acid formation. He teaches courses such as Chemophobia , Inorganic Chemistry , and Advanced Organic Chemistry at NYUAD. Notable contributions include discoveries in homolytic bond activation mechanisms and prebiotically plausible RNA nucleotide synthesis pathways. The Amatov Lab at NYUAD continues to advance sustainable chemical methodologies and origin-of-life studies.
Dr. Gareth Robinson serves as Associate Director of Planning and Partnerships within the Department of Applied Sciences at the University of the West of England's Faculty of Health and Applied Sciences. Holding a PhD and FHEA (Fellow of the Higher Education Academy), he maintains an active research profile while fulfilling administrative responsibilities. His dual role bridges academic research and institutional planning within the university's health sciences framework. Dr. Robinson's research program centers on bacterial bioluminescence applications, with particular expertise in genetic modification of human pathogens using plasmid-borne bacterial lux genes. His work has established innovative methodologies for monitoring antibiotic efficacy, conducting transcytosis and invasion assays with human cell lines, and evaluating novel biocide technologies including non-thermal plasma and aerosol delivery systems. Specializes in developing bioluminescent reporter strains as whole-cell bioreporters Focuses on real-time monitoring of antimicrobial activity in situ Investigates leukemia treatment resistance mechanisms using bioluminescent biosensors Contributes to water safety research through biofiltration studies His publication record demonstrates consistent scholarly output from 2009 through 2025, with recent work expanding into avian influenza impacts on animal populations and advanced leukemia research. Dr. Robinson's interdisciplinary approach bridges microbiology, oncology, and environmental science, particularly through his development of bioluminescent biosensors for real-time monitoring applications. His collaborative work appears across multiple journals and conference presentations, reflecting engagement with both clinical and environmental microbiology communities. While specific awards aren't documented in the available information, Dr. Robinson's research has generated substantial scholarly output with practical applications in healthcare disinfection, antimicrobial testing, and cancer treatment research. His work on electrochemically activated solutions and nonthermal plasma technologies represents significant contributions to biocide development and evaluation methodologies. Dr. Robinson's research program demonstrates strong connections between laboratory science and practical applications, particularly in developing rapid detection methods for biocide efficacy and investigating mechanisms of chemotherapy resistance in leukemia. His work with bioluminescent reporter strains provides valuable tools for real-time monitoring in both clinical and environmental contexts. The Department of Applied Sciences at UWE Bristol serves as the institutional home for his multifaceted research program that spans medical microbiology, biocidal technologies, and cancer research applications.
Beata Liberek is a Professor at the University of Gdańsk , affiliated with the Faculty of Chemistry and the Department of Organic Chemistry . She leads the Laboratory of Glycochemistry , focusing on carbohydrate-based organic synthesis and computational studies of molecular conformations. Research Interests: Glycochemistry, photochemical materials, medicinal compounds, and computational modeling of reaction mechanisms. Recent Publications: Her work includes synthesis of bioactive glycosides, photophysical studies of TADF emitters, and conformational analysis of nucleic acid derivatives. Scientific Contributions: She explores the intersection of organic synthesis, theoretical chemistry, and biomedical applications.
Barbara Dmochowska is an Adjunct Professor at the University of Gdańsk, affiliated with the Faculty of Chemistry, Department of Organic Chemistry, and Laboratory of Carbohydrate Chemistry. Her research focuses on carbohydrate derivatives, quaternary ammonium salts, and molecular dynamics of bioactive compounds. Research Interests : Organic synthesis of carbohydrate-based compounds, mutagenicity studies, computational modeling of reaction mechanisms, and development of antifungal agents. Article Trends : Recent work emphasizes quaternary ammonium salts for pharmaceutical applications, structural analysis of glycosyl compounds, and computational DFT studies of reaction pathways. Laboratory Role : Active member of the Laboratory of Carbohydrate Chemistry, contributing to synthetic methods and biochemical risk assessment.
/zieglmes/sebastian.jpg)
